Metatron Capital SICAV’s Abbott ABT Stock Holding History

Metatron Capital SICAV’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$873K	Buy	+6,200	New	+$794K	0.83%	38

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Metatron Capital SICAV's ABT Position: Q4 2021 in Review

Metatron Capital SICAV opened a new position in Abbott (ABT) in Q4 2021: 6,200 shares worth $873K. The stake represents 0.83% of the portfolio and ranks #38 among its holdings.

2,812 funds tracked by Wall St. Rank hold ABT as of Q4 2021.

Metatron Capital SICAV held 6,200 shares of Abbott worth $873K as of Q4 2021.
Abbott was a new Metatron Capital SICAV position in Q4 2021.
Abbott made up 0.83% of Metatron Capital SICAV's portfolio in Q4 2021, its #38 holding.
2,812 funds tracked by Wall St. Rank held Abbott as of Q4 2021.

Based on Metatron Capital SICAV's 13F filing for Q4 2021, filed 15 Feb 2022.